By Professor Michelle Haber

Preprints

Hu W; Hu W; Kumar A; Qi S; Sadras T; Casan J; Ma D; Brown L; Haber M; Voskoboinik I; Trapani J; Ekert P; Fareh M, 2022, Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions, , http://dx.doi.org/10.21203/rs.3.rs-1714034/v1

Hu W; Kumar A; Qi S; Sadras T; Casan JML; Ma D; Brown L; Haber M; Voskoboinik I; Trapani J; Ekert P; Fareh M, 2022, Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions, , http://dx.doi.org/10.1101/2022.06.22.497105

Nelson C; Rogers S; Roychoudhury K; Tan YS; Atkinson C; Sobinoff A; Tomlinson C; Hsu A; Lu R; Dray E; Haber M; Fletcher J; Cesare A; Hegde R; Pickett H, 2022, The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation, , http://dx.doi.org/10.1101/2022.10.10.511510

Rokita JL; Rathi K; Cardenas M; Upton K; Jayaseelan J; Cross K; Pfeil J; Ritenour L; Modi A; Farrel A; Way G; Kendsersky N; Patel K; Lopez G; Vaksman Z; Mayoh C; Nance J; McCoy K; Haber M; Evans K; McCalmont H; Bendak K; Böhm J; Marshall G; Tyrrell V; Kalletla K; Braun F; Qi L; Du Y; Zhang H; Lindsay H; Zhao S; Shu J; Baxter P; Morton C; Kurmashev D; Zheng S; Chen Y; Bowen J; Bryan A; Leraas K; Coppens S; Doddapaneni H; Momin Z; Zhang W; Sacks G; Hart L; Krytska K; Mosse Y; Gatto G; Sanchez Y; Greene C; Diskin S; Vaske OM; Haussler D; Gastier-Foster J; Kolb A; Gorlick R; Li X-N; Reynolds P; Kurmasheva R; Houghton P; Smith M; Lock R; Raman P; Wheeler D; Maris J, 2019, Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design, , http://dx.doi.org/10.1101/566455

Back to profile page